Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-24
SponsorPoitiers University Hospital

About this trial

This pilot study will be testing the feasibility of medical hypnosis through virtual reality during invasive médical procédures in children and young adults with cancer. Patients age from 7 to under 25 years whose treatement protocols required a lumbure puncture and a chemotherapy by implantable venous access will be randomly assigned to virtual reality or treatement as usual (nitrous oxide, anxiolytics, opioid analgesics, psychotropic and benzodiazepine). We expect the same benefit by using VR as usual intervention.

Eligibility criteria

Qualifiers

Patients aged 7 to strictly under 25

Follow-ups for hematological or oncological pathology

With a lumbar puncture or to connection to an implantable chamber

Patient understanding French

Disqualifiers

Children with cognitive impairment

Children in absolute emergency situations

Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the eyes, face or scalp)

Children who have already participated in the clinical investigation

Trial design

Treatments tested in this trial

  • Virtual Reality
  • Usual Practices

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators